Cargando…

Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study

OBJECTIVES: Recent studies have shown that fecal microbiota transplantation (FMT) improved the metabolic profiles of patients with type 2 diabetes mellitus (T2DM), yet the effectiveness in reversing insulin resistance and increasing metformin sensitivity in T2DM patients have not been reported. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zezhen, Zhang, Bangzhou, Chen, Fengwu, Xia, Rongmu, Zhu, Dan, Chen, Baolong, Lin, Aiqiang, Zheng, Chuyan, Hou, Ducheng, Li, Xiaoyu, Zhang, Shuo, Chen, Yongsong, Hou, Kaijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872724/ https://www.ncbi.nlm.nih.gov/pubmed/36704100 http://dx.doi.org/10.3389/fcimb.2022.1089991

Ejemplares similares

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review
por: Zhang, Shuo, et al.
Publicado: (2022)

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
por: He, Lina, et al.
Publicado: (2022)

Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota
por: Chen, Fengwu, et al.
Publicado: (2022)

Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how
por: Hou, Kaijian, et al.
Publicado: (2022)

Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis
por: Chen, Qiongyun, et al.
Publicado: (2023)

Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets
por: Wang, Hui, et al.
Publicado: (2020)

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential
por: Que, Yanyan, et al.
Publicado: (2021)

Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease
por: Chen, Rongping, et al.
Publicado: (2022)

Fecal Microbiota Changes in Patients With Postpartum Depressive Disorder
por: Zhou, Yumei, et al.
Publicado: (2020)

Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
por: Zhang, Shuo, et al.
Publicado: (2023)

Bibliometric and visual analysis of fecal microbiota transplantation research from 2012 to 2021
por: Zhang, Fengwei, et al.
Publicado: (2022)

Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

Altered Fecal Microbiota Composition in Older Adults With Frailty
por: Xu, YuShuang, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Neurological Disorders
por: Vendrik, Karuna E. W., et al.
Publicado: (2020)

Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
por: Li, Ning, et al.
Publicado: (2021)

Shifts and importance of viable bacteria in treatment of DSS-induced ulcerative colitis mice with FMT
por: Liu, Jinglong, et al.
Publicado: (2023)

The Super-Donor Phenomenon in Fecal Microbiota Transplantation
por: Wilson, Brooke C., et al.
Publicado: (2019)

Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments
por: Chen, Xiaoxia, et al.
Publicado: (2023)

Fecal microbiota as a predictor of acupuncture responses in patients with postpartum depressive disorder
por: Zhou, Yu-Mei, et al.
Publicado: (2023)

Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model
por: Chen, Zhen, et al.
Publicado: (2023)

Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank
por: Chen, Justin, et al.
Publicado: (2021)

Characterization of fecal microbiota in cervical cancer patients associated with tumor stage and prognosis
por: Chang, Lei, et al.
Publicado: (2023)

Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies
por: Bokoliya, Suresh C., et al.
Publicado: (2021)

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)

Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder
por: Deng, Di, et al.
Publicado: (2021)

Gut Microbiota and Fecal Metabolites Associated With Neurocognitive Impairment in HIV-Infected Population
por: Dong, Ruihua, et al.
Publicado: (2021)

Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease
por: Wang, Xinqiong, et al.
Publicado: (2021)

Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
por: Wang, Jieyi, et al.
Publicado: (2022)

The Fecal Microbiota Transplantation: A Remarkable Clinical Therapy for Slow Transit Constipation in Future
por: Liu, Jiafei, et al.
Publicado: (2021)

Fecal Microbiota Signatures in Celiac Disease Patients With Poly-Autoimmunity
por: Bibbò, Stefano, et al.
Publicado: (2020)

Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application
por: Halaweish, Hossam F., et al.
Publicado: (2022)

Crosstalk Between the Gut and Brain: Importance of the Fecal Microbiota in Patient With Brain Tumors
por: Li, Yuping, et al.
Publicado: (2022)

Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Xue, Lanfeng, et al.
Publicado: (2022)

Vitamin D and Lipid Profiles in Postmenopausal Women: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
por: Liu, Weiting, et al.
Publicado: (2021)

Reprogrammed fecal and mucosa-associated intestinal microbiota and weakened mucus layer in intestinal goblet cell- specific Piezo1-deficient mice
por: Liu, Ying, et al.
Publicado: (2022)

Gut microbiota and fecal metabolic signatures in rat models of disuse-induced osteoporosis
por: Qiao, Xiaochen, et al.
Publicado: (2022)

The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
por: Hou, Jueyu, et al.
Publicado: (2021)

Comprehensive Analysis of Gut Microbiota and Fecal Bile Acid Profiles in Children With Biliary Atresia
por: Yang, Ting, et al.
Publicado: (2022)

Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer
por: Lu, Xingbing, et al.
Publicado: (2023)

Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials
por: Li, Yapeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lo3vdcmdli2qpsrdrmpcmcijv8